Cloudbreak Pharma
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8921 Research Dr, Irvine, California, 92...Website
www.cloudbreakpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Cloudbreak Pharma
Cloudbreak Pharma is a clinical stage ophthalmic drug company based in Irvine, CA, founded in September 2015. The company specializes in developing innovative treatments for various ocular diseases, including pterygium, myopia progression, and diabetic macular edema. With a strong focus on ocular R&D, Cloudbreak Pharma has a diverse pipeline of products at different stages of clinical development. Their mission is to enhance patients' quality of life through advanced ophthalmic medications.Explore more
Cloudbreak Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cloudbreak Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Cloudbreak Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Cloudbreak Pharma recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Cloudbreak Pharma had a recent Job posting/layoffs
Check out if Cloudbreak Pharma is spiking on competitors!
Funding: Get notified immidiatlly once Cloudbreak Pharma has new funding data
Congratulate Masked Content for being promoted to Masked Content at Cloudbreak Pharma
Product Launch: Get notified when Cloudbreak Pharma launches new products
Check if Cloudbreak Pharma has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Cloudbreak Pharma
Find 2 more new buyers
Compare Similar Companies to Cloudbreak Pharma
Compare insights from companies similar to Cloudbreak Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cloudbreak Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cloudbreak Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cloudbreak Pharma.
Cloudbreak Pharma Tech Stack
A closer look at the technologies used by Cloudbreak Pharma
See more technologies
Cloudbreak Pharma News & Media
Cloudbreak Pharma Announces Presentation on its Multi-Kinase Inhibition (MKI) Platform and Ongoing Clinical Programs at Eyecelerator @ ARVO 2026
MKIs uniquely block multiple receptor tyrosine kinases (RTKs) simultaneously, addressing the inflammatory, vascular, and fibrotic causes of serious, underserved front-of-the-eye diseasesCloudbreak Pharma Announces Launch of Cloudbreakpharma.com to Raise Awareness of its Pipeline of Novel First-in-Class Therapeutics to Treat Serious Underserved Ophthalmic Diseases
Lead candidate, CBT-001 for the treatment of pterygium, a multi-billion-dollar addressable market, is in mid-Phase 3 with initial topline data anticipated in Q3 2026Cloudbreak Pharma Announces Successful End-of-Phase-2 Meeting and Alignment with FDA on Phase 3 Path Forward for CBT-004
CBT-004, if approved, would be the first and only treatment for pinguecula, an ophthalmic condition impacting more than 50 million people in the U.S. aloneCloudbreak Pharma Soars 80%+ on Multiple Catalysts, Driving Value Re-Rating
HONG KONG, December 11, 2025 - (ACN Newswire) – Since 2025, driven by both policy tailwinds and fundamental strengths, the innovative drug sector in the Hong Kong stock market has experienced a valuation recovery. Although it experienced some correction in the second half due to external environmental factors, its overarching growth logic remains intact. Institutional analysis indicates that innovative drugs continue to represent the clearest industry trend within the pharmaceutical sector, with
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cloudbreak Pharma
Sign Up For FreeTo access detailed company insights
Cloudbreak Pharma is a clinical stage ophthalmic drug company based in Irvine, CA, founded in September 2015. The company specializes in developing innovative treatments for various ocular diseases, including pterygium, myopia progression, and diabetic macular edema. With a strong focus on ocular R&D, Cloudbreak Pharma has a diverse pipeline of pro... Read More
